Karen A Gelmon
Biographic Data
| ID | 5410504 |
|---|---|
| NAME | Karen A Gelmon |
| GIVEN NAMES | Karen A |
| FAMILY NAME | Gelmon |
| SIGNATURE | GELMON K A |
| AFFILIATIONS | BC Cancer Agency |
| ORCID | 0000-0003-4111-2757 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 4 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2013 |
| LATEST PUBLICATION YEAR | 2013 |
| H-INDEX | 1 |
Communication Challenges for Chronic Metastatic Cancer in an Era of Novel Therapeutics
Advances in the production of novel therapies for cancer management are creating new challenges for the support of increasing numbers of persons surviving for extended periods with advanced disease. Despite incurable and life-limiting metastatic conditions, these patients are living longer with serious disease, pushing the boundaries of what science explains and clinicians can confidently interpret using available evidence. Here we report finding…
Communication Challenges for Chronic Metastatic Cancer in an Era of Novel Therapeutics
Advances in the production of novel therapies for cancer management are creating new challenges for the support of increasing numbers of persons surviving for extended periods with advanced disease. Despite incurable and life-limiting metastatic conditions, these patients are living longer with serious disease, pushing the boundaries of what science explains and clinicians can confidently interpret using available evidence. Here we report finding…
Communication Challenges for Chronic Metastatic Cancer in an Era of Novel Therapeutics
Advances in the production of novel therapies for cancer management are creating new challenges for the support of increasing numbers of persons surviving for extended periods with advanced disease. Despite incurable and life-limiting metastatic conditions, these patients are living longer with serious disease, pushing the boundaries of what science explains and clinicians can confidently interpret using available evidence. Here we report finding…
Cancer (1 works) · Cancer survivorship and care (1 works) · Disease (1 works) · Economic and Financial Impacts of Cancer (1 works) · Ethics in Clinical Research (1 works) · Experiential learning (1 works) · Internal Medicine (1 works) · Limiting (1 works) · Medicine (1 works) · Multidisciplinary approach (1 works)